JTJim P. Tol

Jim P. Tol

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jim P. Tol has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Personalized automated treatment planning for breast plus locoregional lymph nodes using Hybrid RapidArc

    by Mariët J. van Duren-Koopman, Jim P. Tol, Max Dahele, Ewa Bucko, Philip Meijnen, Ben J. Slotman, Wilko F. Verbakel


  • A longitudinal evaluation of improvements in radiotherapy treatment plan quality for head and neck cancer patients

    by Jim P. Tol, Patricia Doornaert, Birgit I. Witte, Max Dahele, Ben J. Slotman, Wilko F.A.R. Verbakel


  • Detailed evaluation of an automated approach to interactive optimization for volumetric modulated arc therapy plans

    by Jim P. Tol, Max Dahele, Alexander R. Delaney, Patricia Doornaert, Ben J. Slotman, Wilko F. A. R. Verbakel

    Purpose: Interactive optimization during treatment planning requires intermittent adjustment of organ‐at‐risk (OAR) objectives relative to the dose–volume histogram line. This is a labor‐intensive process and the resulting plans are prone to variations in quality. The authors’ in‐house developed approach to automated interactive optimization (AIO) automatically moves the mouse cursor to adjust the position of on‐screen optimization objectives. This allows for the use of more objectives per OAR and results in a more frequent and consistent adjustment of these objectives during optimization. The authors report a detailed evaluation of AIO performance in support of its implementation for routine head and neck cancer (HNC) planning and an evaluation for locally advanced lung cancer (LC) planning which requires a different optimization strategy.Methods: Volumetric modulated arc therapy AIO plans (APs) were created for 70 HNC patients with a simultaneously integrated boost and 20 LC patients and benchmarked against their respective manually interactively optimized plans (MPs). The same set of optimization objectives and priorities was used for all APs, although planning target volume (PTV) optimization priorities could be increased manually in a subsequent “continue previous optimization” calculation. HNC plans were benchmarked using mean dose to individual and composite OARs and elective/boost PTV (PTVE/PTVB) volumes receiving 95% and 107% of the prescription dose (V95% and V107%, respectively). A clinician performed blinded comparison of 20 APs and respective MPs. LC plans were compared using PTV V95%/V107%, contralateral lung (CL) volume receiving 5 Gy (V5Gy), total lung (TL)‐PTV V5Gy/V20Gy, and esophagus and heart V40Gy/V60Gy/mean doses.Results: For HNC, statistically significant improvements in sparing of all OARs, except for the ipsilateral submandibular gland and trachea, were obtained in the APs compared to MPs. Average mean dose to oral cavity, composite salivary, and swallowing structures were 25.4/23.8, 24.2/23.2, and 29.5/25.5 Gy, respectively, for the MPs/APs. PTV heterogeneity was similar: in the APs, PTVB V95% was 0.2% higher while PTV B/PTV E V107% was 0.4%/1.0% lower. In 19 out of 20 HNC patients, the clinician preferred the AP, mainly because of better OAR sparing and PTV dose homogeneity. For LC, APs had a significantly lower CL V5Gy (6.1%), heart mean dose/V60Gy (0.9 Gy/1.2%) and esophagus mean dose/V60Gy (0.9 Gy/2.8%), a nonsignificantly higher TL V20Gy (1.4%), and a slight, but significantly higher dose deposition to the body. PTV dose coverage and homogeneity were similar in the APs and MPs. AIO was considered sufficiently robust for clinical use in LC.Conclusions: HNC and LC APs were at least as good as, and often of improved quality over MPs. To date, AIO has been clinically implemented for HNC planning.


  • Open Access

    Can knowledge-based DVH predictions be used for automated, individualized quality assurance of radiotherapy treatment plans?

    by Jim P. Tol, Max Dahele, Alexander R. Delaney, Ben J. Slotman, Wilko F. A. R. Verbakel

    Treatment plan quality assurance (QA) is important for clinical studies and for institutions aiming to generate near-optimal individualized treatment plans. However, determining how good a given plan is for that particular patient (individualized patient/plan QA, in contrast to running through a checklist of generic QA parameters applied to all patients) is difficult, time consuming and operator-dependent. We therefore evaluated the potential of RapidPlan, a commercial knowledge-based planning solution, to automate this process, by predicting achievable OAR doses for individual patients based on a model library consisting of historical plans with a range of organ-at-risk (OAR) to planning target volume (PTV) geometries and dosimetries. A 90-plan RapidPlan model, generated using previously created automatic interactively optimized (AIO) plans, was used to predict achievable OAR dose-volume histograms (DVHs) for the parotid glands, submandibular glands, individual swallowing muscles and oral cavities of 20 head and neck cancer (HNC) patients using a volumetric modulated (RapidArc) simultaneous integrated boost technique. Predicted mean OAR doses were compared with mean doses achieved when RapidPlan was used to make a new plan. Differences between the achieved and predicted DVH-lines were analyzed. Finally, RapidPlan predictions were used to evaluate achieved OAR sparing of AIO and manual interactively optimized plans. For all OARs, strong linear correlations (R2 = 0.94–0.99) were found between predicted and achieved mean doses. RapidPlan generally overestimated the amount of achievable sparing for OARs with a large degree of OAR-PTV overlap. RapidPlan QA using predicted doses alone identified that for 50 % (10/20) of the manually optimized plans, sparing of the composite salivary glands, oral cavity or composite swallowing muscles could be improved by at least 3 Gy, 5 Gy or 7 Gy, respectively, while this was the case for 20 % (4/20) AIO plans. These predicted gains were validated by replanning the identified patients using RapidPlan. Strong correlations between predicted and achieved mean doses indicate that RapidPlan could accurately predict achievable mean doses. This shows the feasibility of using RapidPlan DVH prediction alone for automated individualized head and neck plan QA. This has applications in individual centers and clinical trials.


  • Open Access

    Automatic interactive optimization for volumetric modulated arc therapy planning

    by Jim P Tol, Max Dahele, Jarkko Peltola, Janne Nord, Ben J Slotman, Wilko Far Verbakel

    Intensity modulated radiotherapy treatment planning for sites with many different organs-at-risk (OAR) is complex and labor-intensive, making it hard to obtain consistent plan quality. With the aim of addressing this, we developed a program (automatic interactive optimizer, AIO) designed to automate the manual interactive process for the Eclipse treatment planning system. We describe AIO and present initial evaluation data. Our current institutional volumetric modulated arc therapy (RapidArc) planning approach for head and neck tumors places 3-4 adjustable OAR optimization objectives along the dose-volume histogram (DVH) curve that is displayed in the optimization window. AIO scans this window and uses color-coding to differentiate between the DVH-lines, allowing it to automatically adjust the location of the optimization objectives frequently and in a more consistent fashion. We compared RapidArc AIO plans (using 9 optimization objectives per OAR) with the clinical plans of 10 patients, and evaluated optimal AIO settings. AIO consistency was tested by replanning a single patient 5 times. Average V95&V107 of the boost planning target volume (PTV) and V95 of the elective PTV differed by ≤0.5%, while average elective PTV V107 improved by 1.5%. Averaged over all patients, AIO reduced mean doses to individual salivary structures by 0.9-1.6Gy and provided mean dose reductions of 5.6Gy and 3.9Gy to the composite swallowing structures and oral cavity, respectively. Re-running AIO five times, resulted in the aforementioned parameters differing by less than 3%. Using the same planning strategy as manually optimized head and neck plans, AIO can automate the interactive Eclipse treatment planning process and deliver dosimetric improvements over existing clinical plans.


  • Top Cited Papers

    Evaluation of a Knowledge-Based Planning Solution for Head and Neck Cancer

    by Jim P. Tol, Alexander R. Delaney, Max Dahele, Ben J. Slotman, Wilko F.A.R. Verbakel


  • Different treatment planning protocols can lead to large differences in organ at risk sparing

    by Jim P. Tol, Max Dahele, Patricia Doornaert, Ben J. Slotman, Wilko F.A.R. Verbakel


  • Increasing the number of arcs improves head and neck volumetric modulated arc therapy plans

    by Jim P. Tol, Max Dahele, Ben J. Slotman, Wilko F. A. R. Verbakel

    To the Editor, Intensity-modulated radiation therapy (IMRT) is particularly useful for treating irregularly shaped planning target volumes (PTVs) whilst minimizing doses to organs at risk (OARs). V...